World's Best Scientists 2026 revealed!
Carmen Jerónimo

Carmen Jerónimo

D-Index & Metrics

Biology and Biochemistry

D-Index
74
Citations
18214
World Ranking
5643
National Ranking
20

Overview

Carmen Jerónimo is affiliated with the University of Porto in Portugal and has contributed extensively to research in biochemistry, genetics, molecular biology, and medicine. Their work spans various subfields, including molecular biology, cancer research, surgery, pulmonary and respiratory medicine, and oncology.

The scientist's research focuses primarily on several key topics, including:

  • Epigenetics and DNA Methylation
  • Testicular diseases and treatments
  • Cancer Genomics and Diagnostics
  • Prostate Cancer Treatment and Research
  • Bladder and Urothelial Cancer Treatments
  • MicroRNA in disease regulation
  • Histone Deacetylase Inhibitors Research

Carmen Jerónimo has published prolifically in numerous scientific venues. The most frequent publication outlets include:

  • Cancers
  • International Journal of Molecular Sciences
  • Clinical Epigenetics
  • European Urology Open Science
  • bioRxiv (Cold Spring Harbor Laboratory)

Recent notable papers authored or coauthored by Jerónimo cover a range of topics related to cancer biology and diagnostics. These include:

  • DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types, 2020, published in Cells
  • Data Sharing Under the General Data Protection Regulation, 2021, published in Hypertension
  • VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer, 2020, published in Cancers
  • Shifting the Cancer Screening Paradigm: The Rising Potential of Blood-Based Multi-Cancer Early Detection Tests, 2023, published in Cells
  • Genome-Wide DNA Methylation Profiling of Esophageal Squamous Cell Carcinoma from Global High-Incidence Regions Identifies Crucial Genes and Potential Cancer Markers, 2021, published in Cancer Research

Collaborative efforts form an important part of Jerónimo's work, with frequent coauthors including:

  • Rui Henrique
  • João Lobo
  • Vera Constâncio
  • Vera Miranda-Gonçalves
  • Nuno Tiago Tavares

Best Publications

  • P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.

    Joana Paredes;André Albergaria;João T. Oliveira;Carmen Jerónimo

  • Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.

    Paul Cairns;Manel Esteller;James G. Herman;Mark Schoenberg

  • Human cancer cell antiproliferative and antioxidant activities of Juglans regia L.

    Márcia Carvalho;Pedro J. Ferreira;Vanda S. Mendes;Renata Silva

  • Quantitative Adenomatous Polyposis Coli Promoter Methylation Analysis in Tumor Tissue, Serum, and Plasma DNA of Patients with Lung Cancer

    Henning Usadel;Jan Brabender;Kathy D. Danenberg;Carmen Jerónimo

  • Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.

    Carmen Jerónimo;Henning Usadel;Rui Henrique;Jorge Oliveira

  • A quantitative promoter methylation profile of prostate cancer.

    Carmen Jerónimo;Rui Henrique;Rui Henrique;Mohammad O. Hoque;Elizabeth Mambo

  • Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors

    Montserrat Sanchez-Cespedes;Paola Parrella;Shuji Nomoto;Daniel Cohen

  • TMPRSS2-ERG Gene Fusion Causing ERG Overexpression Precedes Chromosome Copy Number Changes in Prostate Carcinomas and Paired HGPIN Lesions

    Nuno Cerveira;Franclim R. Ribeiro;Ana Peixoto;Vera Costa

  • The Timeline of Epigenetic Drug Discovery: From Reality to Dreams

    A. Ganesan;Paola B. Arimondo;Marianne G. Rots;Carmen Jeronimo

  • Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.

    Mohammad O. Hoque;Qinghua Feng;Papa Toure;Amadou Dem

  • Mitochondrial mutations in early stage prostate cancer and bodily fluids.

    Carmen Jerónimo;Shuji Nomoto;Otávia L Caballero;Henning Usadel

  • Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.

    Mohammad Obaidul Hoque;Shahnaz Begum;Ozlem Topaloglu;Carmen Jeronimo

  • Epigenetics in prostate cancer: biologic and clinical relevance

    Carmen Jerónimo;Patrick J. Bastian;Anders Bjartell;Giuseppina M. Carbone

  • Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer

    Carmen Jerónimo;Henning Usadel;Henning Usadel;Rui Henrique;Rui Henrique;Cristina Silva;Cristina Silva

  • Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma

    André Lopes Carvalho;Carmen Jeronimo;Michael M. Kim;Rui Henrique

  • Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis.

    Michael F. Spafford;Wayne M. Koch;Andre L. Reed;Joseph A. Califano

  • Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome

    Mohammad Obaidul Hoque;Myoung Sook Kim;Kimberly Laskie Ostrow;Junwei Liu

  • Diagnostic and prognostic epigenetic biomarkers in cancer.

    Pedro Costa-Pinheiro;Diana Montezuma;Rui Henrique;Carmen Jerónimo

  • Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples

    Vera L. Costa;Vera L. Costa;Rui Henrique;Rui Henrique;Stine A. Danielsen;Sara Duarte-Pereira

  • Molecular detection of prostate cancer: a role for GSTP1 hypermethylation.

    Rui Henrique;Carmen Jerónimo

Frequent Co-Authors

Rui Henrique
Rui Henrique University of Porto
Manuel R. Teixeira
Manuel R. Teixeira University of Porto
David Sidransky
David Sidransky Johns Hopkins University School of Medicine
Paula Guedes de Pinho
Paula Guedes de Pinho University of Porto
Ragnhild A. Lothe
Ragnhild A. Lothe University of Oslo
Maria de Lourdes Bastos
Maria de Lourdes Bastos University of Porto
Rolf Inge Skotheim
Rolf Inge Skotheim Oslo University Hospital
Joseph A. Califano
Joseph A. Califano University of California, San Diego
Leendert H. J. Looijenga
Leendert H. J. Looijenga Princess Máxima Center
Francisco S. N. Lobo
Francisco S. N. Lobo University of Lisbon

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens the door to a range of exciting online degrees and career opportunities in healthcare and life sciences. Many students explore options beyond traditional lab-based roles. For example, combining scientific training with business through an affordable online mba healthcare management program can prepare graduates for leadership roles in hospitals, biotech, or pharmaceutical companies.

If you're interested in the administrative or data-driven side of healthcare, medical coding and billing careers offer strong prospects. Understanding the differences between ccs vs cpc certification is an important first step, as these credentials impact your job responsibilities and earning potential.

Curious about job outlook and compensation? Learn more about what is medical coding salary and typical growth in this sector. Weighing your future career options? Discover if is medical billing and coding a good career for your goals and interests. These pathways are all accessible with a strong background in Biology or Biochemistry, offering flexible and meaningful career routes in healthcare.

Best Scientists Citing Carmen Jerónimo

Trending Scientists

Recently Published Articles